CVE-2026-28971Disclosure(apple / ipados)

LOWCVSS 4.3 · MEDIUM

Signal is active with 1 mentions in latest observed window

Immediate actions

  • Track advisory updates for patch or workaround availability

Recommended action window: Monitor and triage in normal cycle

NVD description

The issue was addressed with improved UI handling. This issue is fixed in Safari 26.5, iOS 26.5 and iPadOS 26.5, macOS Tahoe 26.5, visionOS 26.5. A malicious iframe may use another website’s download settings.

0.5/ 10 priority

Sources & remediation

Weakness type (CWE)
CWE-1021

Priority

LOW

Exploitation

NONE

PoC

NONE

Patch

NONE

Momentum

NONE

Are you affected?

If you run products in this scope, you should treat this CVE as relevant to your environment.

  • ipados
  • iphone_os
  • macos
  • visionos

Threat summary

  • 1 mentions across 1 observed day

What's happening

  • Technical details provided in 1 signal
  • Disclosure: 1 classified signal
  • 1 total mentions across 1 day

Affected systems

Vendors
Products
ipadosiphone_osmacosvisionos

Deep dive

Activity timeline1 mentions / 1d
00111Mentions · 2026-05-16: 1Technical Details · 2026-05-16: 105-16
Signal classification1 categories
Disclosure
1100.0%
Referenced assets1 URL
By indicator
Full discourse1 post
  • Israel@f1tym1
    Disclosure

    CVE-2026-28971 | Apple iOS/iPadOS/macOS/visionOS up to 26.4 UI Handler access control (WID-SEC-2026-1543) https://ift.tt/YLUBc21 A vulnerability described as critical has been identified in Apple iOS, iPadOS, macOS and visionOS up to 26.4. This impacts an unknown function of t…

    Post summary

    Apple has publicly disclosed a critical UI handler access control flaw (CVE-2026-28971) impacting iOS, iPadOS, macOS, and visionOS up to 26.4, with limited technical details and no known exploitation or mitigation information provided here.

    0000065
    974 followersView on X
CPE platform detail4 entries

4 of 4 entries

PartVendorProductVersionTarget SWTarget HW
OSappleipados---
OSappleiphone_os---
OSapplemacos---
OSapplevisionos---

Explore more